Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schmalzing

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Scandinavian Journal of Rheumatology|September 27, 2019
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapyE C Schwaneck, R Renner, L Junker, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 5, 2004
Gordonia polyisoprenivorans septicemia in a bone marrow transplant patientV A J Kempf, M Schmalzing, A F Yassin, et al.
Scandinavian Journal of Rheumatology|July 18, 2019
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritisF Behrens, M Koehm, E C Schwaneck, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytomaR Burger, A Guenther, F Bakker, et al.
Zeitschrift Fur Rheumatologie|August 22, 2024
Castleman's disease in the rheumatological practiceM Schmalzing, O Sander, M Seidl, et al.
Zeitschrift Fur Rheumatologie|February 24, 2019
Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jawE C Schwaneck, A Streit, M Krone, et al.
Zeitschrift Fur Rheumatologie|August 25, 2023
[Castleman's disease in the rheumatological practice]M Schmalzing, O Sander, M Seidl, et al.
Leukemia|January 11, 2012
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemiaH Pfeifer, T Lange, S Wystub, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Scandinavian Journal of Rheumatology|September 27, 2019
T cells, natural killer cells, and γδT cells in a large patient cohort with rheumatoid arthritis: influence of age and anti-rheumatic therapyE C Schwaneck, R Renner, L Junker, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 5, 2004
Gordonia polyisoprenivorans septicemia in a bone marrow transplant patientV A J Kempf, M Schmalzing, A F Yassin, et al.
Scandinavian Journal of Rheumatology|July 18, 2019
Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritisF Behrens, M Koehm, E C Schwaneck, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytomaR Burger, A Guenther, F Bakker, et al.
Zeitschrift Fur Rheumatologie|August 22, 2024
Castleman's disease in the rheumatological practiceM Schmalzing, O Sander, M Seidl, et al.
Zeitschrift Fur Rheumatologie|February 24, 2019
Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jawE C Schwaneck, A Streit, M Krone, et al.
Zeitschrift Fur Rheumatologie|August 25, 2023
[Castleman's disease in the rheumatological practice]M Schmalzing, O Sander, M Seidl, et al.
Leukemia|January 11, 2012
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemiaH Pfeifer, T Lange, S Wystub, et al.
Arthritis Care & Research|June 1, 2019
Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic SclerosisD Belz, P Moinzadeh, G Riemekasten, et al.
Zeitschrift Fur Rheumatologie|February 11, 2020
[Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany]A Juche, E Siegert, U Mueller-Ladner, et al.
Pageof 4